ATP degradation products after ischemic exercise
Tulio E. Bertorini(University of Tennessee Health Science Center), Irving H. Fox(Takeda (United States)), Vera P. Shively(University of Nebraska at Omaha), Bonnie Taylor(University of Tennessee Health Science Center), Genaro M. A. Palmieri(University of Tennessee Health Science Center)
Cited by 26
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694